Video from ECR 2018: Alexander Radbruch on gadolinium retention

March 2, 2018

VIENNA - The debate over the safety of gadolinium-based contrast agents for MRI shows no sign of going away, and U.S.-style lawsuits filed against radiologists and vendors in Europe is now a distinct possibility. Dr. Alexander Radbruch, JD, head of neuro-oncologic imaging at the German Cancer Research Center in Heidelberg and University Hospital Essen, is both a lawyer and a radiologist, and he presents his views and ideas on this controversial topic.

Video loading ...

Dr. Alexander Radbruch, JD, from Heidelberg and Essen.

Video produced by Christof. G. Pelz I GRAFIFANT Creation. Grafik. Photo I www.grafifant.at

If you like this content, please share it with a colleague!

Related Reading

Video from ECR 2018: Wiro Niessen on how AI can help you
VIENNA - Don't feel threatened by artificial intelligence (AI). That's the view of Wiro Niessen, PhD, of the Netherlands. In the first of today's three...

Safety issues linger over gadolinium-based contrast agents
Conclusive research into the safety of gadolinium-based contrast agents could take about a decade to emerge because of the huge difficulties of obtaining...

No gadolinium needed for follow-up MRI inner ear scans
VIENNA - Once an initial MRI scan with gadolinium-based contrast has confirmed an intralabyrinthine schwannoma, the contrast agent shouldn't be needed...

Video from ECR 2018: Bernd Hamm on Brexit, AI, and the big chill
VIENNA - Brexit will have no impact on the relationship between the European Society of Radiology and the U.K. Royal College of Radiologists, said ECR...

Some side effects of the great gadolinium scare
The news about gadolinium is having side effects -- many radiologists now are too scared to use any gadolinium-based contrast agent. But have the effects...